Literature DB >> 2891045

Analysis of the nature of antagonism of the reserpine-induced hypothermia by imipramine.

H Francès1.   

Abstract

Antagonism of reserpine-induced hypothermia is an animal model used in the screening of antidepressants. The activity of imipramine on this test is partly impaired by propranolol. This effect of imipramine was analyzed using specific adrenoceptor and 5-HT receptor blocking drugs in order to determine the nature of this effect of propranolol. The non-selective beta 1-beta 2 adrenoceptor antagonist, propranolol as the specific beta 1 adrenoceptor antagonist betaxolol, but not the specific beta 2 blocking drug DL-erythro-3-isopropylamino-1-(7-methyl-4-indanyloxy)-2-butanol hydrochloride 313.9 (ICI 118,551), partly antagonized the effect of imipramine at 30 min. None of the serotonin (5-HT) receptor antagonists, methysergide, metergoline, ritanserin and buspirone, impaired the effect of imipramine. On the contrary, methysergide alone antagonized reserpine-induced hypothermia and methysergide or metergoline increased the action of imipramine. Propranolol impaired neither the hypothermia induced by an agonist at the 5-HT 1A receptors: 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) nor the increase in spontaneous motor activity induced by an agonist at the 5-HT 1B receptors: 5-methoxy-3(1,2,3,6-tetrahydropyridin-4-yl)1-H indole (Ru 24,969). It is concluded that the effect of propranolol is not the result of a blockade of 5-HT 1A, 5-HT 1B or 5-HT 2, but is in part due to blockade of beta 1 adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2891045     DOI: 10.1007/bf00172682

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  (-)-Propranolol inhibits the behavioural responses of rats to increased 5-hydroxytryptamine in the central nervous system.

Authors:  A R Green; D G Grahame-Smith
Journal:  Nature       Date:  1976-08-12       Impact factor: 49.962

2.  [Action of caffeine on the spontaneous motility of the mouse].

Authors:  J R Boissier; P Simon
Journal:  Arch Int Pharmacodyn Ther       Date:  1965-11

3.  Antagonism by d,1-propranolol of imipramine effects in mice.

Authors:  M Souto; H Francès; Y Lecrubier; A J Puech; P Simon
Journal:  Eur J Pharmacol       Date:  1979-11-23       Impact factor: 4.432

4.  Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding.

Authors:  S J Peroutka; S H Snyder
Journal:  Science       Date:  1980-10-03       Impact factor: 47.728

5.  High-affinity 3H-imipramine binding in rat cerebral cortex.

Authors:  R Raisman; M Briley; S Z Langer
Journal:  Eur J Pharmacol       Date:  1979-03-01       Impact factor: 4.432

6.  A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.

Authors:  G M Goodwin; A R Green
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

7.  Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol.

Authors:  D N Middlemiss
Journal:  Eur J Pharmacol       Date:  1984-06-01       Impact factor: 4.432

8.  Presynaptic serotonin receptor-mediated response in mice attenuated by antidepressant drugs and electroconvulsive shock.

Authors:  G M Goodwin; R J De Souza; A R Green
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

9.  (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists.

Authors:  J S Sprouse; G K Aghajanian
Journal:  Eur J Pharmacol       Date:  1986-09-09       Impact factor: 4.432

10.  Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome.

Authors:  L M Smith; S J Peroutka
Journal:  Pharmacol Biochem Behav       Date:  1986-06       Impact factor: 3.533

View more
  1 in total

1.  Wettability and contact angle affect precorneal retention and pharmacodynamic behavior of microspheres.

Authors:  Hanyu Liu; Xinyue Han; Huamei Li; Qi Tao; Jie Hu; Shuo Liu; Huaixin Liu; Jun Zhou; Wei Li; Fan Yang; Qineng Ping; Shijie Wei; Hongmei Liu; Huaqing Lin; Dongzhi Hou
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.